ABALLI JOHN (President and CEO) sold 1.6% of their position (11.43K shares) of EXAGEN INC. on the open market
Open‑market sale worth $41.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001843113-26-000002
DirectorOfficer· President and CEO
Since Mar 2026
-11.43K
Net shares
Net seller
$41.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.43K
Price / share
$3.61
Trade value
$41.26K
% of position
1.6%
2/24/2026
714.43K→703K
Total
Net shares
−11.43K
Net value
-$41.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −11.43K | $3.61 | $41.26K | 1.6% | 714.43K | 703K |
| Total | −11.43K | -$41.26K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.40K
Total
40.40K indirect40.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.40K | Indirect |
| Total | 40.40K | 40.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported